Generic combination products simplify treatment by merging drugs and delivery devices into one system, improving adherence by 15-25%. They cut costs by 30-80% and work just as well as brand-name versions-when patients get proper training.
Details
Atazanavir is a key protease inhibitor used in combination HIV therapy to suppress viral load and preserve immune function. It's known for once-daily dosing, low side effect burden, and effectiveness in first-line treatment when paired with NRTIs like tenofovir and emtricitabine.
Details